Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Vigil Neuroscience Inc
VIGLCurrent price
3.87 USD
+0.07 USD (+1.84%)
Last closed
3.78 USD
Company
www.vigilneuro.com
ISIN
US92673K1088
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
150 264 048 USD
Yield for 12 month
-43.75 %
1Y
3Y
5Y
10Y
15Y
VIGL
Vigil Neuroscience, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. Its lead candidate is VGL101(Iluzanebart), a human monoclonal antibody agonist targeting human triggering receptor expressed on myeloid cells 2 and is in a Phase 2 trial in patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), a rare and fatal neurodegenerative disease. The company is also developing VG-3927, an orally-available small molecule TREM2 agonist to treat common neurodegenerative diseases associated with microglial dysfunction, with an initial focus on Alzheimer's disease in genetically defined subpopulations, which is being evaluated in a Phase 1 clinical trial. It has license agreement with Amgen Inc. to commercially develop, manufacture, use, distribute, and sell therapeutic products containing compounds that bind to TREM2. The company was incorporated in 2020 and is headquartered in Watertown, Massachusetts. Address: 100 Forge Road, Watertown, MA, United States, 02472
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
15.88 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-399 000 USD
Last Year
-1 010 000 USD
Current Quarter
-113 000 USD
Last Quarter
-113 000 USD
Key Figures VIGL
1 year
3 years
5 years
10 years
EBITDA
-89 622 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-39.66 %
PEG Ratio
–
Return On Equity TTM
-70.12 %
Wall Street Target Price
15.88 USD
Revenue TTM
–
Book Value
2.27 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-2.11 USD
Diluted Eps TTM
-2.11 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics VIGL
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History VIGL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation VIGL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-3.162
Price Book MRQ
1.6645
Financials VIGL
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators VIGL
For 52 weeks
2.47 USD
7.82 USD
50 Day MA
3.52 USD
Shares Short Prior Month
526 549
200 Day MA
3.44 USD
Short Ratio
5.31
Shares Short
513 298
Short Percent
2.05 %
BeatStart